Devices In Drug Land: Med-Tech Firms Try To Break Into Pharma Territory
This article was originally published in The Gray Sheet
Executive Summary
Medical device companies are targeting everything from headaches to psychiatric disorders and from digestive diseases to cardiac conditions in an effort to win over just a portion of these and other multibillion-dollar drug-dominated markets
You may also be interested in...
Dialysis For Heart Failure? FDA Panel Urges Randomized Trials First
Randomized clinical trials are needed to allow blood filtration devices to be labeled for heart failure treatment, according to FDA's gastroenterology and urology devices panel
Dialysis For Heart Failure? FDA Panel Urges Randomized Trials First
No standard exists for the amount of fluid removal necessary to achieve positive outcomes for various conditions, even with diuretic drugs – the current standard of care for medical management of fluid overload.
Dialysis For Heart Failure? FDA Panel Urges Randomized Trials First
Randomized clinical trials are needed to allow blood filtration devices to be labeled for heart failure treatment, according to FDA's gastroenterology and urology devices panel